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Background: The occupational therapy (OT) in care homes study (OTCH) aims to investigate the effect of a
targeted course of individual OT (with task training, provision of adaptive equipment, minor environmental
adaptations and staff education) for stroke survivors living in care homes, compared to usual care.
Methods/Design: A cluster randomised controlled trial of United Kingdom (UK) care homes (n = 90) with residents
(n = 900) who have suffered a stroke or transient ischaemic attack (TIA), and who are not receiving end-of-life care.
Homes will be stratified by centre and by type of care provided and randomised (50:50) using computer generated
blocked randomisation within strata to receive either the OT intervention (3 months intervention from an
occupational therapist) or control (usual care). Staff training on facilitating independence and mobility and the use
of adaptive equipment, will be delivered to every home, with control homes receiving this after the 12 month
follow-up.
Allocation will be concealed from the independent assessors, but the treating therapists, and residents will not be
masked to the intervention. Measurements are taken at baseline prior to randomisation and at 3, 6 and 12 months
post randomisation. The primary outcome measure is independence in self-care activities of daily living (Barthel
Activities of Daily Living Index). Secondary outcome measures are mobility (Rivermead Mobility Index), mood
(Geriatric Depression Scale), preference based quality of life measured from EQ-5D and costs associated with each
intervention group. Quality adjusted life years (QALYs) will be derived based on the EQ-5D scores. Cost effectiveness
analysis will be estimated and measured by incremental cost effectiveness ratio. Adverse events will be recorded.
Discussion: This study will be the largest cluster randomised controlled trial of OT in care homes to date and will
clarify the currently inconclusive literature on the efficacy of OT for stroke and TIA survivors residing in care homes.
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A systematic review and meta-analysis by Legg et al. [1]
of nine trials (1258 participants) found that in stroke
survivors, occupational therapy (OT) increased personal
activities of daily living scores (i.e., standardised mean
difference 0.18; 95% confidence interval 0.04 to 0.32;
p = 0.01). Furthermore, for every 100 people who
received OT after a stroke, 11 (95% confidence interval 7
to 30) would be spared a poor outcome (i.e., death, de-
terioration in personal activities of daily living or de-
pendency on others; Odds ratio 0.67; 95% confidence
interval 0.51 to 0.87; p = 0.003). A care setting where OT
might be particularly beneficial is in care homes, where
20% to 40% of all people newly admitted have stroke-
related disabilities as their admittance diagnosis [2,3].
Generalisation of results from community studies should
be treated with caution, as the characteristics of stroke
survivors resident in a care home are likely to be differ-
ent to those living in their own homes. For instance,
78% of residents in a care home have cognitive impair-
ment, 76% need some form of assistance with ambula-
tion and 71% are incontinent [2]. These factors might
affect the capacity of care home residents to engage in
OT.
OT in care homes has been embraced in countries
such as The Netherlands, where 93% of residents regu-
larly receive this form of therapy [4], in contrast to the
United Kingdom (UK), where as few as 3% of residents
in care homes receive OT [5]. Over the last decade, the
government in the UK has established a framework to
assess eligibility and prioritise care needs of residents
[6,7]. However, a recent audit of 112 care homes in the
Midlands area of the UK found that only 6% of homes
used the services of an OT at least once a week [8]. The
under-utilisation of OT in this setting might be the re-
sult of staff being unaware of the role of an occupational
therapist and/or how to access the services. Conversely,
from a service commissioner’s perspective there is little
evidence that the provision of OT services for care
homes residents following a stroke is effective and/or
cost-effective [8].
In the literature there is conflicting evidence on the ef-
ficacy of OT for on activities of daily life in care homes
residents with stroke-related disabilities [9-11]. For in-
stance, a study by Sackley et al. [9], which involved 249
care homes residents with mobility limitations, found
that after a three month OT and physiotherapy
programme there was no measureable improvements in
functional independence and mobility. Although the
findings suggest the therapy intervention to be ineffect-
ive, it could be argued that therapists in this study deliv-
ered interventions to maintain physical abilities of the
residents rather than actively rehabilitate them. Further-
more, the therapy was applied relatively unselectively toall care home residents, rather than specifically targeted
towards care homes residents with stroke-related disabil-
ities. A cluster randomised trial, which evaluated the ef-
fect of OT compared to usual care over 3 months in 118
residents with a stroke-related disability at 12 care
homes, found that residents who received OT were less
likely to deteriorate in their ability to perform activities
of daily living [10]. From baseline to 3 months the mean
Barthel Activities of Daily Living Index (Barthel index)
score had increased by 0.6 (SD= 3.9) in the intervention
group, but decreased by 0.9 (SD= 2.2) in the control
group. This equated to a difference between the groups
of 1.5 and 95% confidence interval of -0.5 to 3.5 (allow-
ing for a cluster design). The difference between the
groups in Barthel index was maintained at 6 months
(i.e., difference of 1.9 and 95% confidence interval of -0.7
to 4.4). The sample size was very small especially when
taking into account the high intra class correction (ICC)
of 0.37 (Barthel index at baseline), which is consistent
with the ICC of 0.39 found in a subsequent pilot study
of incontinence care in the same setting [11].
The findings from these studies demonstrate that even
modest levels of OT may have detectable and lasting
effects on morbidity and possibly mortality. It would,
therefore, be appropriate to replicate the study with a
larger sample to investigate the clinical impact of OT on
activities of daily life in care homes residents with
stroke-related disabilities.
In addition to the investigation of clinical impact of
OT, a larger sample size will enable a full assessment of
the economic impact that OT has on providing health
care. Previous work in Canada [12] and in the UK [13]
investigated the cost of OT in care homes, based on
cost-consequence analyses. The Canadian study studied
two types of OT and physiotherapy intensities, which
compared 1 therapist to 50 bed ratio to 1 therapist to
200 bed ratio. Improvements in functional outcome
measures favoured OT and physiotherapy delivered at
the 1:50 ratio, which resulted in reduced direct nurse
time and equated to an annual saving of 283 Canadian
dollars per resident [12]. The study conducted in the
UK, examined the effect of OT on levels of depression
and quality of life in care homes residents [13]. It was
found that, at 2005 levels, the net cost of providing the
OT service was 16 British pounds per resident per week.
However, it was suggested by the authors that OT might
have resulted in a reduction in overall health costs [13].
Both studies suggest that providing OT to residents in a
care homes incurs an initial cost to health care provi-
ders, but generates savings in the long-term through the
improvement of functional outcomes of residents with-
out stroke-related disabilities [12,13]. There is, therefore,
a need to analyse the economic impact of OT on resi-
dents with stroke-related disabilities in care homes.
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cluster randomised control trial to evaluate the effects of
the provision of OT, which include task related training,
the provision of adaptive equipment, minor environmen-
tal adaptations and staff education, compared to usual
care, on activities of daily living, mobility, depression
and quality of life for residents with stroke-related dis-
abilities in care homes. Allocation of therapy cannot be
concealed from the carers and/or residents so, to min-
imise contamination of intervention, the unit of ran-
domisation will be the care home. Furthermore, we aim
to conduct a health economic evaluation of the effect of
the provision of OT services has on the health care sys-
tem compared to usual care. Given the findings of previ-
ous studies on clinical [1,9-11] and health economic
[12,13] impact of OT compared to usual care in the UK
[5,8], it is hypothesised that the provision of OT services
will have a favourable impact on activities of daily living,
and reduce long-term costs to health care providers.
Methods/Design
Design
This study is a pragmatic stage III cluster randomised
controlled trial with health economic evaluation. The
flow diagram for this trial is presented in Figure 1. and
follows the CONSORT extension for cluster randomised
trials [14].
Setting
Care homes for older people in the UK from Birmingham,
Bangor, Coventry, Portsmouth, Nottingham, Central
Lancashire, Peninsula, Staffordshire and Wolverhampton
areas. We will include all funding models of homes (i.e. pri-
vate, charitable, not for profit and local authority). Homes
for people with learning disabilities or drug addiction will
be excluded from the study.
Recruitment and consent
Care homes
Care home managers will be approached and provided
with information about the study. They will be given a
full oral explanation of the study, a leaflet describing OT
and study information sheets. Care home managers will
be asked to give written agreement for their home to
participate in the study. Following this, residents will be
recruited individually.
Residents
Care home managers will assist to identify potential par-
ticipants. Participants must be resident in a care home
and have a history of stroke or transient ischaemic attack
(TIA). All efforts will be made to include participants
with communication and cognitive impairments, be-
cause this will more accurately reflect the populationcharacteristics. Participants will be excluded from the
study if they are receiving end-of-life care (with life
expectancy< 6 months). Care home members of staff
will search residents’ notes to determine a diagnosis of
stroke or TIA. If required, we will confirm this diagnosis
with general practice records. When a potential partici-
pant is identified as being eligible for the study, they and
(where appropriate) their family (outlined in the UK’s
Mental Capacity Act 2005 [15]) will be approached by a
senior member of the care home staff, a research net-
work nurse or therapist, general practitioner or geriatri-
cian, and will be asked if they are interested in
participating in a research study. Prospective participants
(and their family) will be given a full explanation of the
study. This will include discussion of the treatment
options in the trial and the manner of treatment alloca-
tion. Potential participants and their family will be given
a participant information sheet, or a consultee informa-
tion sheet and the UK Clinical Research Network’s 2007
[16] publication on ‘Understanding Clinical Trials’ to
read. They will be given sufficient time to decide (at least
24 hours) whether they would like to join the study. This
may take a few days if relatives only visit at weekends
for example. Residents will then be asked to sign the
consent form. If the resident is considered to be incapa-
citated, according to the Mental Capacity Act 2005
guidelines [15], a family member (consultee) will be
approached for consent. The participant’s general practi-
tioner will be informed, if the patient or consultee con-
sents, in writing of their participation in the trial.
Research nurses from NHS research networks will assist
in the recruitment and consent processes.
Randomisation
Homes and participants will be recruited and consented
into the study before the randomisation process com-
mences to reduce bias [17,18]. Homes will be stratified
by residential care homes providing personal care and
homes providing additional nursing care. Once the study
co-ordinator (KES) receives confirmation from the asses-
sors that all residents in a participating home have given
their consent and completed a baseline assessment, the
homes will be grouped and randomised (50:50) to re-
ceive either the OT intervention or control (usual care).
The assignment of cluster to either the OT intervention
or control arm of the study will be conducted by the
study co-ordinator. They contact the managers of the
homes directly and make arrangements for the occupa-
tional therapist to visit the care home to commence the
intervention. The allocation sequence will be generated
by a statistician (AKR) using blocked randomisation
within strata (centre and type of home; residential, nurs-
ing) at the Primary Care Clinical Research and Trials
Unit at the University of Birmingham, independent from
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Figure 1 Flow diagram of the progress of clusters and individuals through phases of the trial.
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unknown to any of the assessors or to the study co-
ordinator. Allocation will be concealed from the inde-
pendent assessors, but it is not possible to mask the
treating therapists or residents from the intervention.
The success of blinding will be evaluated at each follow-
up stage by asking the assessors to record if the alloca-
tion has been revealed to them.
Intervention
We developed an OT intervention package for residents
in a care home using evidence and consensus from a
previous study [19]. The OT intervention will beprovided by qualified occupational therapists and assis-
tants and will be targeted towards improving independ-
ence in activities of daily living, such as feeding,
dressing, toileting, bathing, transferring and mobilising.
Adaptive equipment will be provided as part of the study
and will include personal items, such as adapted cutlery
and walking aids. Furthermore, adaptations to the indivi-
dual's environment might need to be made, such as chair
raisers, bed levers, raised toilet seats or grab rails. When
adaptive equipment or adaptations to the environment
have been provided to the resident, the occupational
therapist will demonstrate to them and the care staff
how to use the equipment effectively, whilst adhering to
Table 1 Proposed assessment schedule
Assessment Time of administration
Baseline 3 months 6 months 12 months
Demographics ✓
Sheffield Screening
Test*
✓
Mini Mental State
Examination
✓
Barthel Activity of
Daily Living Index
✓ ✓ ✓ ✓
Rivermead Mobility
Index
✓ ✓ ✓ ✓
Geriatric Depression
Scale
✓ ✓ ✓ ✓
EQ-5D ✓ ✓ ✓ ✓
Resource Use Log ✓ ✓ ✓
Adverse Event Log ✓ ✓ ✓
*Full name of the test is Sheffield Screening Test for Acquired Language
Disorders.
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OT will be dependent on the resident and therapist’s
agreed goals (within the framework of the home). In the
pilot study, the number of face-to-face sessions ranged
from 1 to 25 per resident over a three-month period
(median time = 8.5 hours and mean time = 4.7 hours),
dependent on the individual needs of the resident [19].
The OT intervention will follow a ‘client centred ap-
proach’ [20] and will include a continuous process of as-
sessment, treatment and reassessment. In line with
current evidence on effective treatment, the OT inter-
vention will adopt a task-specific training approach [21].
Treatment logs have been developed in which the dose
and focus of OT intervention can be documented. This
will allow for accurate costing for health care services to
residents in care homes to be calculated. Care homes in
the control arm of the study will continue to provide
their usual care to residents (i.e. continue providing (or
not) any therapy as they would do usually).
Training for care home staff
Specific training will be given for staff involved in the
care of the residents receiving active therapy. In
addition, all intervention homes will be offered a group
training session on the key principles of OT by the occu-
pational therapist. A half-day group training session for
care home staff has been developed and summarised, on
the facilitation of independent daily living activities and
mobility of residents [22].
Care homes in the control arm will receive similar train-
ing, but only after the 12 month follow-up assessment has
been completed. It is anticipated that delivering the training
to the control group will facilitate compliance and reduce
loss to follow-up in the control group. This, in turn, will re-
duce the potential bias during the follow-up period [19].
Outcome measures
Demographic data
Information recorded by a member of staff from the care
home about the resident will include age, gender, current
medication intake and date, type and side of stroke. Fur-
thermore, at baseline a trained assessor will administer
the Sheffield Screening Test for Acquired Language Dis-
orders, to assess receptive/expressive aphasia [23], and
the mini mental state examination to assess cognitive
function [24]. Finally, data on resource use will be
recorded through logs and collected from health and so-
cial care services to conduct a health economic evalu-
ation for both interventions delivered during this study.
Primary outcome measure
The primary outcome measure is the Barthel Activity of
Daily Living Index [25], which is a commonly used measure
of independent self-care in people who survived a stroke[26,27]. Furthermore, the Barthel index assesses specific
aspects of self care targeted by the therapy. A change of
two points on this scale is widely accepted as being clinic-
ally meaningful [28]. The Barthel index can be completed
by the resident or with assistance from a member of staff.
Secondary outcome measures
Secondary outcome measures will assess mobility, mood,
safety, quality of life and costs. Mobility will be assessed
with the Rivermead mobility index [29], which is a 15-
item measurement of functional mobility. The geriatric
depression scale [30] will be administered to measure
mood. The full 30-item version will be used as standard,
but in cases where residents are unable to self complete
or follow and interview the informant version will be
filled out. Quality of life is measured by the EQ-5D [31],
which is a well established measure for evaluating
patients preference. Costs will be estimated based on re-
source usage log and weighted by unit costs. This will
include visits to hospital and include in- and out-patient
appointments, allied health professionals time, general
practitioner visits, provision of care in a care home,
adaptive equipment, minor environmental adaptations
and staff education. Unit costs will be obtained from the
national health and social care services reference costs
and personal social services research unit [32]. Addition-
ally, any adverse events will be recorded in participant
logs and will include a fall or equipment failure leading
to an injury requiring a visit to a hospital or general
practitioner.
Assessment schedule
An overview of the assessment schedule is given in
Table 1. Baseline assessments will be conducted prior to
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tition [33]. The primary measurement point will be at
3 months after randomisation and follow-up assessments
will be conducted at 6 and 12 months prior to random-
isation. Data will be collected from participants where
they are currently residing. If a participant moves to an-
other home between assessments, then the assessors will
attempt to collect follow-up data.
Sample size
A sample of 330 residents in each arm will be sufficient
to identify a clinically meaningful 2-point change in the
Barthel index. This estimate is based on a standard devi-
ation of 3.7 [10], 90% power, 5% level of significance and
an ICC of 0.4 [10,11]. Given that the trial will be a clus-
ter randomised trial, it is predicted that 33 homes with
10 residents in each will be required in each arm of the
study. Based on the attrition rate of 26% from a previous
study [10], it is predicted that 45 homes with 10 resi-
dents in each will be required in each arm of the study
(i.e., 900 residents in total).
Statistical analysis
Baseline characteristics of participants will be tabulated
by treatment arm. Items will include demographic
details of residents, past medical history, questionnaires;
and breakdown of the number of care homes and cluster
size.
Primary analysis
The primary outcome is the mean Barthel index score at
the 3 month follow-up. A mixed model analysis will be
used to compare Barthel index scores between the inter-
vention and control groups. The primary analysis will be
adjusted by care home (as a random factor), baseline
Barthel index score, and stratification factors: centre and
type of care home (nursing, residential). Participants that
die before their follow-up date will be given a Barthel
index score of zero at all subsequent follow-ups. In
addition, participants will be categorised into 3 out-
come groups based on an individual’s change in Barthel
index score at 3 months from baseline (below 0 or
death = ‘poor’, 0 to 1=’moderate’, 2 and above=’good’). A
non-linear mixed effects model will be used to compare
this ordinal outcome between the groups. Adjustments
will be made for care home (random), centre and type
of care home (fixed).
Secondary analysis
To identify any longer term effects, a repeated measures
mixed model analysis of the primary outcome will be
undertaken, comparing groups across all time points.
The analysis will include adjustment for care home (as a
random factor), baseline Barthel index score, andstratification factors: centre and type of care home. Simi-
lar analyses will be performed for mobility, mood and
quality of life.
The number of falls will be compared using a Poisson
or negative binomial model, with adjustments for care
home, centre and type of care home as previously
described. A sensitivity analysis of the outcomes will be
performed to examine the potential effect of missing
data. This will include best case, worst case and multiple
imputation methods.
Analysis will be by intention to treat, whereby residents
will be analysed according to the intervention to which they
are randomised, regardless of whether they comply with
the treatment. All participants irrespective of when they
die, withdraw or are lost will be included in the arm to
which they were randomised, including those that die after
consent but prior to randomisation. Those participants that
move home will be analysed by the home they were origin-
ally randomised to. Analyses will be performed using Stata
(StataCorp,. Texas, USA) and SAS software (SAS Institute
Inc., Cary, NC).
Health economic evaluation
Outcomes from health economic evaluation analyses will
establish cost effectiveness of a treatment expressed as
incremental cost per quality-adjusted life-years (QALYs)
gained. Generalised linear models will be used to investi-
gate differences between interventions for QALYs and
costs. Bootstrap methods will be adopted to produce in-
cremental cost effectiveness ratio and associated confi-
dence intervals. Cost-effectiveness acceptability curves
will be generated to reflect the probability that a treat-
ment will be cost effective given a society’s willingness to
pay in terms of price per QALY gained.
Governance
Ethical approval
Favourable ethical opinion for this study was obtained
from the National Research Ethics Service, Coventry Re-
search Ethics Committee (Reference: 09/H1210/88). The
study was granted an International Standard Rando-
mised Controlled Trial Number (00757750).
Trial management
A trial steering group has been established to monitor the
governance of the study consisting of the main research
team, an independent chair, a geriatrician, an occupational
therapist, a physiotherapist with expertise in rehabilitation
research a patient representative, and a representative from
the National Institute for Health Research. A data monitor-
ing committee has been established with an independent
geriatrician as chair, a statistician and an occupational ther-
apist. During the development of this protocol, a patient
representative was consulted.
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Service user (and carer) involvement will be incorpo-
rated at all levels of this study. Service user (and carer)
involvement will not be a ‘stand-alone’ activity but rather
an integral part of all aspects of this study. Service users
(and carers) will be directly involved as research ‘part-
ners’ and not just as ‘data providers’. All support for ser-
vice users (and carers) involvement will be provided by
the Stroke Research Network members who have expert-
ise in training and supporting service users (and carers)
for involvement in National Health Service research, ser-
vice evaluation and development.
Discussion
The methodological limitations and considerations of
cluster randomised trials are well reported [34] and have
been addressed in the current study protocol. Further-
more, the choice of clustering design to reduce interven-
tion contamination was a key component of the
development of this trial. Previous cluster randomised
trials demonstrated that a relatively small level of OT
may have detectable and relatively long-lasting effects on
morbidity and possibly mortality in care homes residents
with stroke-related disabilities [10,11]. These studies en-
rolled small numbers of clusters and participants and
were conducted in specific areas of the UK, which
reduces the generalisability of the findings to residents
in care homes more widely. The current study will be
the largest cluster randomised control trial of OT in care
homes to date. It will provide clinically relevant informa-
tion on the effect of OT services on activities of daily life
compared to usual care. Furthermore, it aims to estab-
lish the effects of OT services on aspects such as mobil-
ity, depression and quality of life, which are major
challenges experienced by many residents [2]. Finally,
this study will evaluate the health economic impact of
OT services compared to usual care. In combination, the
findings of this large scale cluster randomised controlled
trial will assist in the formulation of UK guidelines and
policies on the provision of OT services for residents
with stroke-related disabilities in care homes.
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